251. Urea cycle disorder
42 clinical trials,   45 drugs   (DrugBank: 10 drugs),   4 drug target genes,   29 drug target pathways

Other name(s) = "N-acetylglutamate synthase deficiency", "NAGS deficiency", "Carbamoyl phosphate synthetase I deficiency", "CPS1 deficiency", "Ornithine transcarbamylase deficiency", "OTC deficiency", "Classic citrullinemia", "Citrullinemia type I", "Argininosuccinic aciduria", "Argininemia", "Hiperornitinemia-hiperamonemia-homocitrulinuria syndrome", "HHH syndrome"

Specific pediatric chronic diseases, Japan
• 8-1-11. N-acetylglutamate synthetase deficiency
• 8-1-12. Carbamoylphosphate synthetase deficiency
• 8-1-13. Ornithine transcarbamylase deficiency
• 8-1-14. Argininosuccinate synthetase deficiency; Citrullinaemia type 1
• 8-1-15. Argininosuccinic aciduria
• 8-1-16. Hyperarginemia
• 8-1-18. Hyperornithinemia